TABLE 2.
Characteristics | MRMP* n = 285 (100) | MSMP* n = 72 (100) | Total n = 357 (100) | P a |
---|---|---|---|---|
BMI | 18.14 ± 4.24 | 17.35 ± 3.04 | 17.98 ± 4.04 | 0.374 |
Respiratory admission history, n (%) | 44 (15.4) | 20 (27.8) | 64 (17.9) | 0.035 |
Hospital admission duration (day) | 7.23 ± 4.30 | 6.36 ± 2.67 | 7.06 ± 4.04 | 0.374 |
Incident season | 0.376 | |||
Spring (Mar, Apr, May) | 29 (10.2) | 5 (6.9) | 34 (9.5) | |
Summer (Jun, Jul, Aug) | 3 (1.1) | 2 (2.8) | 5 (1.4) | |
Autumn (Sep, Oct, Nov) | 127 (44.6) | 38 (52.8) | 165 (46.2) | |
Winter (Dec, Jan, Feb) | 126 (44.2) | 27 (37.5) | 153 (42.9) | |
Febrile days after initiation of antibiotic medication (day) | 2.44 ± 2.23 | 1.58 ± 1.84 | 2.27 ± 2.18 | 0.007 |
Hypoxia (SpO 2 < 93%) | 15 (5.3) | 2 (2.8) | 17 (4.8) | 0.376 |
Pleural effusion, n (%) | 36 (12.6) | 2 (2.8) | 38 (10.6) | 0.035 |
Note: Values are presented as numbers (%) and mean ± standard deviation. Numbers in bold indicate significant differences (P < 0.05). Scale variables were analyzed using the chi‐squared test or Fisher exact test, and continuous variables were analyzed using Student's t‐test or Mann–Whitney U‐test.
Abbreviations: MRMP, macrolide‐resistant Mycoplasma pneumoniae; MRMP*, macrolide‐resistant M. pneumoniae with admission; MSMP, macrolide‐susceptible M. pneumoniae; MSMP*, macrolide‐susceptible M. pneumoniae with admission.
P was analyzed using a false discovery rate for multiplicity.